These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Virtual screen for ligands of orphan G protein-coupled receptors. Bock JR, Gough DA. J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917 [Abstract] [Full Text] [Related]
4. Using silico methods predicting ligands for orphan GPCRs. Jiang Z, Zhou Y. Curr Protein Pept Sci; 2006 Oct; 7(5):459-64. PubMed ID: 17073696 [Abstract] [Full Text] [Related]
5. Synergistic Use of GPCR Modeling and SDM Experiments to Understand Ligand Binding. Potterton A, Heifetz A, Townsend-Nicholson A. Methods Mol Biol; 2018 Oct; 1705():335-343. PubMed ID: 29188570 [Abstract] [Full Text] [Related]
6. GPCR Homology Model Generation for Lead Optimization. Tautermann CS. Methods Mol Biol; 2018 Oct; 1705():115-131. PubMed ID: 29188560 [Abstract] [Full Text] [Related]
7. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number? Vass M, Kooistra AJ, Verhoeven S, Gloriam D, de Esch IJP, de Graaf C. Methods Mol Biol; 2018 Oct; 1705():73-113. PubMed ID: 29188559 [Abstract] [Full Text] [Related]
8. Bioinformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization. Colette J, Avé E, Grenier-Boley B, Coquel AS, Lesellier K, Puget K. J Pept Sci; 2007 Sep; 13(9):568-74. PubMed ID: 17694568 [Abstract] [Full Text] [Related]
9. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling. Coudrat T, Simms J, Christopoulos A, Wootten D, Sexton PM. PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821 [Abstract] [Full Text] [Related]
10. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands. Kooistra AJ, Roumen L, Leurs R, de Esch IJ, de Graaf C. Methods Enzymol; 2013 Nov; 522():279-336. PubMed ID: 23374191 [Abstract] [Full Text] [Related]
11. Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity. Jaiteh M, Rodríguez-Espigares I, Selent J, Carlsson J. PLoS Comput Biol; 2020 Mar; 16(3):e1007680. PubMed ID: 32168319 [Abstract] [Full Text] [Related]
12. Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery. Heifetz A, Southey M, Morao I, Townsend-Nicholson A, Bodkin MJ. Methods Mol Biol; 2018 Mar; 1705():375-394. PubMed ID: 29188574 [Abstract] [Full Text] [Related]
13. The ligand-independent translocation assay: an enabling technology for screening orphan G protein-coupled receptors by arrestin recruitment. Oakley RH, Hudson CC, Sjaastad MD, Loomis CR. Methods Enzymol; 2006 Mar; 414():50-63. PubMed ID: 17110186 [Abstract] [Full Text] [Related]
18. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor. Chen H, Fu W, Wang Z, Wang X, Lei T, Zhu F, Li D, Chang S, Xu L, Hou T. ACS Chem Neurosci; 2019 Jan 16; 10(1):677-689. PubMed ID: 30265513 [Abstract] [Full Text] [Related]
19. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs. Bartuzi D, Kaczor AA, Matosiuk D. Methods Mol Biol; 2018 Jan 16; 1705():297-319. PubMed ID: 29188568 [Abstract] [Full Text] [Related]